Livongo Health, Inc. reported consolidated unaudited earnings results for the fourth quarter and full year ended December 31, 2019. For the quarter, revenue was $50,356,000 against $21,206,000 reported a year ago. Loss from operations was $7,721,000 against $13,124,000 reported a year ago. Net loss was $6,043,000 against $12,460,000 reported a year ago. Net loss per share attributable to common stockholders, basic and diluted was $0.06 against $0.72 reported a year ago.

For the year, revenue was $170,198,000 against $68,431,000 reported a year ago. Loss from operations was $60,381,000 against $34,995,000 reported a year ago. Net loss was $55,270,000 against $33,382,000 reported a year ago. Net loss per share attributable to common stockholders, basic and diluted was $1.09 against $2.02 reported a year ago.

For the year 2020, the company expects revenue to grow between 65% and 71% to the range of $280.0 million to $290.0 million, ahead of preliminary guidance of approximately $276.0 million.

For the first quarter of 2020, the company expects revenue in the range of $60.0 million to $62.0 million.